Beta Healthcare International

What Beta Healthcare International does

Beta Healthcare International Ltd is a Nairobi-headquartered pharmaceutical manufacturer and wholly-owned subsidiary of South Africa's Aspen Group (acquired 100% in 2012, after Aspen's initial 60% stake in 2008). Operating continuously since 1942 (rebranded to its current name in 1996), the company manufactures over-the-counter medicines and prescription-only medicines spanning analgesics, antibiotics, cardiovascular, respiratory, gastrointestinal, dermatological, and nutritional categories, with a current portfolio of 16 OTC SKUs and 21 prescription SKUs. Manufacturing capabilities encompass oral solids (tablets, capsules, powders, ORS), oral liquids, and external liquids, supported by QC laboratories equipped with HPLC, FTIR, UV-Vis spectrophotometers, particle size analyzers, and stability chambers, plus an in-house R&D centre opened in 2012.

The company operates an integrated distribution model combining direct in-house van sales, third-party distributors, and wholesalers to reach hospitals, pharmacies, retail shops, supermarkets, and informal dukas across Kenya, with export operations covering 20+ African countries across East, Central, West, Southern, and French West Africa. Regulatory positioning is a core commercial asset: Beta Healthcare holds current Good Manufacturing Practice (cGMP) approvals from 12+ African national regulatory authorities, alongside ISO 14001:2015 and ISO 45001:2018 certifications for its Kenya operations.

Commercially, Beta Healthcare monetizes through one-time sales of pharmaceutical products across two primary streams (OTC consumer healthcare and prescription institutional supply), with the brand portfolio anchored by legacy brands acquired from GlaxoSmithKline (Hedex, Cofta, Decavit Plus, Cafenol, Ashton & Parsons) and AstraZeneca (Diprivan, Marcaine, Xylocaine, Xyloproct). Within Aspen Group, the entity functions as the Regional Head Office for Sub-Saharan Africa, coordinating operations across Kenya, Tanzania (Shelys Pharmaceuticals), and Ghana (Kama Industries).

Name

Beta Healthcare International

Legal name

Beta Healthcare International Ltd

Website

https://betacare.co.ke

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Beta Healthcare International is a Nairobi-based pharmaceutical manufacturer and wholly-owned subsidiary of Aspen Group, producing OTC and prescription medicines across 37 SKUs for hospitals, pharmacies, retailers, and export markets spanning 20+ African countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Cold, Flu & Cough Remedies (HLAIADAB)

akta.pro secondary industries

Vitamins, Minerals & Supplements (VMS) (HLAIADAN), Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Pharmaceutical manufacturing
• Over-the-counter medicines
• Prescription pharmaceuticals
• Generic medicines
• CGMP manufacturing

Headquarters

HQ city

Nairobi

HQ country

Kenya

HQ region

Africa

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Over-the-Counter (OTC) Medicines Sales: Sale of non-prescription pharmaceutical products directly to consumers through retail shops, wholesale, supermarkets, pharmacies and dukas. Products include pain relievers, cough/cold remedies, digestive products, and nutritional supplements.
2. Prescription Only Medicines (POM): Sale of prescription pharmaceutical products including antibiotics, chronic disease medications (diabetes, cancer, heart conditions) distributed through hospitals, pharmacies and healthcare institutions.
3. Export/Distribution: Manufacturing and distribution of medicines to export markets across East Africa, Central Africa, West Africa, Southern Africa and French West Africa regions.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

Beta Healthcare International is a pharmaceutical manufacturer that produces and distributes over-the-counter (OTC) medicines, prescription-only medicines (POM), and branded generics across Sub-Saharan Africa. The company manufactures oral solids (tablets, capsules, powders, oral rehydration salts), oral liquids and external liquids, operating as a wholly-owned subsidiary of Aspen Group with cGMP approvals from 12+ African regulatory authorities. Its 37+ product portfolio spans analgesics, antibiotics, cough/cold remedies, cardiovascular, respiratory, and pediatric treatments.

Product overview

Beta Healthcare International is a pharmaceutical manufacturer offering a diverse portfolio of OTC (Over-the-Counter) medicines and Prescription Only Medicines (POM). The OTC portfolio includes 16 products spanning analgesics (Action, Hedex, Mara Moja), cough/cold remedies (Cofta, Good Morning, Koflyn), digestive aids (Beta Gripe Water, Woodwards Gripe Water), nutritional supplements (Hemovit, Ped Zinc), and topical treatments (Salimia Liniment, Opele lotion). The POM portfolio includes 21 prescription products covering antibiotics (Azuma, Septrin, Mucolyn), cardiovascular medicines (Aldomet, Eltroxin), analgesics (Betafen Plus, Coldril), respiratory treatments (Muco-Asthalin, Koflyn syrups), and other therapeutic categories. The company operates as an Aspen Group subsidiary, manufacturing at its Nairobi facility with cGMP approvals across multiple African regulatory authorities and exports to over 20 African countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Action Tablets Analgesic tablet combining Aspirin 600mg, Paracetamol 300mg, and Caffeine Anhydrous 50mg for relief of headache, colds and flu, muscular aches, menstrual discomfort, toothache and sinusitis; sold over-the-counter to consumers.
• Action Advance Tablets Analgesic OTC tablet for relief of headache, migraines, backache, toothache, rheumatic pain, dysmenorrhea, and cold/flu symptoms.
• Beta Gripe Water OTC relief of gripes, excess acid and flatulence in infants and children.
• Cafenol Extra Tablets OTC pain relief tablet with aspirin and caffeine for treatment of painful and febrile conditions.
• Cofta Extra Syrup OTC cough and cold syrup containing Tolu Solution, Capsicum Tincture, Creosote, Anise oil, and Liquorice for coughs, bronchitis and symptomatic relief from colds and catarrh.
• Cofta Tablets OTC cough relief tablet containing Glycyrrhiza Extract, Menthol and various oils for symptomatic relief of coughs, colds and catarrh.
• Good Morning Lung Tonic OTC Tolu-based tonic for treatment of coughs and bronchitis and symptomatic relief from colds and catarrh.
• Good Morning Cough Tablets OTC herbal cough tablet containing Pulvis Glycyrrhiza, Menthol, Eucalyptus Oil for relief of dry irritating cough and throat soothing.
• Hedex Caplets OTC analgesic caplet combining Aspirin, Paracetamol and Caffeine for treatment of painful and febrile conditions.
• Hemovit Syrup

Quantifiable outcome

• cGMP certified manufacturing compliant with 12+ African regulatory authorities
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered minor.

• Pharmaceutical Supply Chain Initiative (PSCI)minorOthersBeta Healthcare participates in industry collaborations that improve supply chain environmental, social and governance (ESG) practices through PSCI membership.
• GlaxoSmithKline (GSK)minorOthersAcquired established brands including Hedex, Cofta, Decavit Plus, Cafenol, and Ashton & Parsons from GSK, strengthening therapeutic portfolio and brand equity.
• AstraZenecaminorOthersAcquired brands including Diprivan, Marcaine, Xylocaine, and Xyloproct from AstraZeneca, expanding product portfolio.

Scale indicators5 records

Recent moves13 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

• Xx.com/aspenssa
• YouTubeyoutube.com/@AspenSubSaharanAfrica-SSA
• Facebookfacebook.com/aspenssa
• LinkedInlinkedin.com/company/beta-health-care-international-limited
• Instagraminstagram.com/aspenssa
• TikToktiktok.com/@aspenssa

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beta Healthcare International